2.96Open2.96Pre Close0 Volume1.04K Open Interest22.50Strike Price0.00Turnover67.52%IV7.09%PremiumDec 20, 2024Expiry Date1.47Intrinsic Value100Multiplier24DDays to Expiry1.49Extrinsic Value100Contract SizeAmericanOptions Type-0.6124Delta0.1048Gamma9.05Leverage Ratio-0.0274Theta-0.0088Rho-5.54Eff Leverage0.0209Vega
Viridian Therapeutics Stock Discussion
somehow lost on $NIO Inc (NIO.US)$ earlier but we can't stop won't stop 😂😭
2 MINUTES AGO, 4:01 PM EDT
VIA BUSINESSWIRE
📊⚡️📊
Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease
Viridian Therapeutics (NASDAQ: VRDN) announced positive topline results from the THRIVE Phase 3 clinical trial of veligrotug (VRDN-001) in patients with active thyroid eye disease (TED). The trial met all primary and secondary endpoints, showing significant improvements in proptosis, diplopia, and clinic...
$Day One Biopharmaceuticals (DAWN.US)$ $Viridian Therapeutics (VRDN.US)$ $Bristol-Myers Squibb (BMY.US)$ $BioNTech (BNTX.US)$
FIRST SIGNED OF MORE UPTREND: $24.19
NEED IT TO BREAK OVER: $24.28
key indicator for MORE uptrend $24.47
confirmation uptrend - $24.65
mini breakout - $24.84. $Viridian Therapeutics (VRDN.US)$
• $Funko (FNKO.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $Southwest Airlines (LUV.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $MetLife (MET.US)$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment (MTG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake (SNOW.US)$ : JPMorgan Upgrades to Overweigh...
No comment yet